BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BioAtla, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026
- Market cap
- $2.18M
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about BioAtla from other investors
No posts about BCAB yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.